These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16263755)

  • 1. Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation.
    Kao C; Daniels MA; Jameson SC
    Int Immunol; 2005 Dec; 17(12):1607-17. PubMed ID: 16263755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally occurring low affinity peptide/MHC class I ligands can mediate negative selection and T cell activation.
    Motyka B; Teh HS
    J Immunol; 1998 Jan; 160(1):77-86. PubMed ID: 9551958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.
    Nugent CT; Renteria RO; Kuus-Reichel K; Kumar A
    Immunol Lett; 2005 May; 98(2):208-15. PubMed ID: 15860220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD8 isoform CD8alphaalpha is not a functional homologue of the TCR co-receptor CD8alphabeta.
    Gangadharan D; Cheroutre H
    Curr Opin Immunol; 2004 Jun; 16(3):264-70. PubMed ID: 15134773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of CD8beta-mediated T cell response enhancement: interaction with MHC class I/beta2-microglobulin and functional coupling to TCR/CD3.
    Wheeler CJ; Chen JY; Potter TA; Parnes JR
    J Immunol; 1998 May; 160(9):4199-207. PubMed ID: 9574520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells.
    Schott E; Ploegh HL
    Eur J Immunol; 2002 Dec; 32(12):3425-34. PubMed ID: 12432573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of thymocyte deletion by purified single peptide/major histocompatibility complex ligands.
    Lesage S; Charron J; Winslow G; Hugo P
    J Immunol; 1997 Sep; 159(5):2078-81. PubMed ID: 9278291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes.
    Luescher IF; Vivier E; Layer A; Mahiou J; Godeau F; Malissen B; Romero P
    Nature; 1995 Jan; 373(6512):353-6. PubMed ID: 7830771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosynapse formation coincides with rapid activation of NK cells by syngeneic T cells and correlates with clustering of MHC class I.
    Rabinovich BA; Li J; Hurren R; Miller RG
    Int Immunol; 2005 Jun; 17(6):671-6. PubMed ID: 15899925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct stimulation of naïve T cells by antigen-presenting cell vesicles.
    Sprent J
    Blood Cells Mol Dis; 2005; 35(1):17-20. PubMed ID: 15932799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of peptide-selected CD8 T cells in fetal thymic organ culture occurs via the conventional pathway.
    Hogquist KA; Bonnevier JL
    J Immunol; 1998 Oct; 161(8):3896-901. PubMed ID: 9780155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding.
    Cole DK; Dunn SM; Sami M; Boulter JM; Jakobsen BK; Sewell AK
    Mol Immunol; 2008 May; 45(9):2700-9. PubMed ID: 18243322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-avidity CD8lo T cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8hi T cell responses to the same antigen.
    Maile R; Pop SM; Tisch R; Collins EJ; Cairns BA; Frelinger JA
    Eur J Immunol; 2006 Feb; 36(2):397-410. PubMed ID: 16402405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.
    Liu SD; Tomassian T; Bruhn KW; Miller JF; Poirier F; Miceli MC
    J Immunol; 2009 May; 182(9):5283-95. PubMed ID: 19380775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of cytotoxic T-lymphocyte activation by soluble CD8.
    Sewell AK; Gerth UC; Price DA; Purbhoo MA; Boulter JM; Gao GF; Bell JI; Phillips RE; Jakobsen BK
    Nat Med; 1999 Apr; 5(4):399-404. PubMed ID: 10202928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development.
    Ford MS; Chen W; Wong S; Li C; Vanama R; Elford AR; Asa SL; Ohashi PS; Zhang L
    Eur J Immunol; 2007 Aug; 37(8):2234-41. PubMed ID: 17578845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
    Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
    Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides.
    Hammer GE; Gonzalez F; James E; Nolla H; Shastri N
    Nat Immunol; 2007 Jan; 8(1):101-8. PubMed ID: 17128277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.